Clinical Center for NICHD/Neonatal Research Network
Clinical Center for NICHD/Neonatal Research Network
批准号:
10681621
负责人:
Sara Bonamo DeMauro
金额:
$39.82万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
未结题
起止时间:
2011-04-01 至 2030-03-31
关键词:
Admission activityAgeAwardCaringClinicClinicalClinical ResearchClinical TrialsCollaborationsConduct Clinical TrialsCountryEducationEnrollmentEnsureEpidemiologic MethodsFacultyFollow-Up StudiesFundingFutureGoalsHybridsInfantInformed ConsentInpatientsInterventionLactationLeadershipManuscriptsMilrinoneMissionMulticenter Neonatal Research NetworkNational Institute of Child Health and Human DevelopmentNeonatalNeonatal Intensive Care UnitsNeonatologyObservational StudyOutcomeOutcome StudyOutpatientsPediatric HospitalsPennsylvaniaPerinatalPerinatologyPhiladelphiaPrincipal InvestigatorProductivityProtocols documentationPublicationsPublishingRandomized Controlled Clinical TrialsRecordsResearchResearch MethodologyResearch PersonnelResourcesSample SizeScheduleSchool-Age PopulationScientific Advances and AccomplishmentsSecureServicesSiteSolidStructureTechniquesTransfusionU-Series Cooperative AgreementsUniversitiesVisitWritingclinical careclinical centerclinical trial enrollmentclinical trial protocolcohortevidence baseextreme prematurityfetal diagnosisfollow-uphealth disparityhigh risk infantimproved outcomeinnovationmedical schoolsmeetingsmembermicrobiomenovelparticipant enrollmentpatient populationpediatric departmentprematurepreterm newbornrandomized trialrecruitsuccesssymposium
中文摘要
项目总结
尤尼斯·肯尼迪·施莱弗NICHD合作多中心新生儿研究网络(NRN)致力于
为照顾患病和早产儿提供强有力的科学依据,促进健康
结果。自2011年以来,宾夕法尼亚大学佩雷尔曼医学院(宾夕法尼亚大学)和儿童
费城医院(CHOP)临床中心一直在各个方面做出重大贡献
NRN研究。我们的临床中心包括三个大型三级新生儿重症监护病房
围产期中心、一家儿童医院的一个大型四级病房和三个后续诊所,所有这些都是
统一在宾夕法尼亚大学/CHOP新生儿学部的领导下。我们是领先的NRN临床中心
用于招聘、留住和学习跟踪。我们在目前的15家临床中心中排名第三
婴儿被招募到目前正在进行的五项随机试验中。宾夕法尼亚大学/CHOP大学2年随访率为
持续高于NRN的平均随访率。自从我们加入NRN以来,我们一直在进行后续
在宾夕法尼亚大学/CHOP研究参与者中,98.5%(391人中的385人)18-26个月的就诊时间纠正了年龄
临床试验。我们的调查人员和协调员在NRN内部发挥着重要的领导作用,在
多个小组委员会,并通过NRN开放网络机制促进新中心的启动。
我们的首席调查员领导了两项关于NRN试验和Penn/CHOP的大型学龄期后续研究
自我们上次竞争续签以来,调查人员已经以第一作者或高级作者的身份发表了27篇NRN手稿。
我们还通过我们团队在创新流行病学技术方面的专业知识做出了独特的贡献
和健康差距。我们已作好充分准备,继续积极参与北大西洋公约组织,贡献我们的
团队在临床研究方法方面的特殊优势,作为合作伙伴和富有成效的合作伙伴在
正在进行的研究,并推出创新的新议定书,以推进NICHD NRN的科学任务
在下一个颁奖周期。
英文摘要
PROJECT SUMMARY
The Eunice Kennedy Shriver NICHD cooperative multicenter Neonatal Research Network (NRN) is committed
to providing a strong scientific evidence base for the care of sick and preterm newborns to promote healthy
outcomes. Since 2011, the University of Pennsylvania Perelman School of Medicine (Penn) and Children’s
Hospital of Philadelphia (CHOP) Clinical Center has been making significant contributions to all aspects of
NRN research. Our Clinical Center includes three large level three neonatal intensive care units in academic
perinatal centers, one large level four unit in a children’s hospital, and three follow-up clinics, all of which are
unified under the leadership of the Penn/CHOP Division of Neonatology. We are a leading NRN Clinical Center
for recruitment, retention, and study follow-up. We rank #3 among the 15 current Clinical Centers for number of
infants recruited into the five currently ongoing randomized trials. Penn/CHOP 2-year follow-up rates are
consistently higher than NRN average follow-up rates. Since we joined the NRN, we have conducted follow-up
visits at 18-26 months corrected age in 98.5% (385 of 391) of Penn/CHOP study participants enrolled in 9
clinical trials. Our investigators and coordinators provide important leadership within the NRN, serving on
multiple subcommittees and facilitating startup of new centers through the NRN Open Network mechanism.
Our Principal Investigator leads two large school-age follow-up studies of NRN trials and Penn/CHOP
investigators have published 27 NRN manuscripts as first or senior author since our last competitive renewal.
We also provide unique contributions through our team’s expertise in innovative epidemiological techniques
and health disparities. We are fully prepared to continue our robust participation in the NRN by contributing our
team’s special strengths in clinical research methodology, collaborating as collegial and productive partners in
ongoing studies, and introducing innovative new protocols to advance the scientific mission of the NICHD NRN
in the next award cycle.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Center for NICHD/Neonatal Research Network
-
批准号:10841989
-
项目类别:
-
资助金额:$33.55万
-
财政年份:2023
-
负责人:Sara Bonamo DeMauro
-
依托单位:
3/24 Healthy Brain and Child Development National Consortium
-
批准号:10494123
-
项目类别:
-
资助金额:$136.52万
-
财政年份:2021
-
负责人:Sara Bonamo DeMauro
-
依托单位:
Neonatal Treatment Trial
-
批准号:10379584
-
项目类别:
-
资助金额:$52.8万
-
财政年份:2021
-
负责人:Sara Bonamo DeMauro
-
依托单位:
3/24 Healthy Brain and Child Development National Consortium
-
批准号:10661751
-
项目类别:
-
资助金额:$128.8万
-
财政年份:2021
-
负责人:Sara Bonamo DeMauro
-
依托单位:
Neonatal Treatment Trial
-
批准号:10891303
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2021
-
负责人:Sara Bonamo DeMauro
-
依托单位:
HBCD Study Biospecimens Administrative Supplement: Resource Generation for Delivery Specimens
-
批准号:10748467
-
项目类别:
-
资助金额:$27.6万
-
财政年份:2021
-
负责人:Sara Bonamo DeMauro
-
依托单位:
3/24 Healthy Brain and Child Development National Consortium
-
批准号:10378902
-
项目类别:
-
资助金额:$101.83万
-
财政年份:2021
-
负责人:Sara Bonamo DeMauro
-
依托单位:
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center
-
批准号:9370603
-
项目类别:
-
资助金额:$31.94万
-
财政年份:2017
-
负责人:Sara Bonamo DeMauro
-
依托单位:
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center
-
批准号:10473774
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2017
-
负责人:Sara Bonamo DeMauro
-
依托单位:
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center
-
批准号:10165348
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2017
-
负责人:Sara Bonamo DeMauro
-
依托单位:
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center
-
批准号:10685517
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2017
-
负责人:Sara Bonamo DeMauro
-
依托单位:
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center
-
批准号:10240303
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2017
-
负责人:Sara Bonamo DeMauro
-
依托单位:
1/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Clinical Coordinating Center
-
批准号:10018078
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2017
-
负责人:Sara Bonamo DeMauro
-
依托单位:
Clinical Center for NICHD/Neonatal Research Network
-
批准号:10352225
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2011
-
负责人:Sara Bonamo DeMauro
-
依托单位:
Clinical Center for NICHD/Neonatal Research Network
-
批准号:10348105
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2011
-
负责人:Sara Bonamo DeMauro
-
依托单位:
Clinical Center for NICHD/Neonatal Research Network
-
批准号:9899278
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2011
-
负责人:Sara Bonamo DeMauro
-
依托单位:
Outcomes of Babies with Opioid Exposure (OBOE)
-
批准号:9901878
-
项目类别:
-
资助金额:$87.59万
-
财政年份:--
-
负责人:Sara Bonamo DeMauro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: